Delivery Order SPE2DB22D3501-SPE2DB24FUK07

Award Date 1/30/24
Potential Completion Date 1/31/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $8,172.60 to supply TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $5,727.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen, 0.5 ml. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which enables the DLA to efficiently...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,781.33 contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This award is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,019.20 firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for 4,565 units of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order valued at $1,741.68 for the supply of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,787.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. This award is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to provide a comprehensive range of medications and medical supplies to support the Department of Defense's...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $4,801.87 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of a pharmaceutical product, TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, with a period of performance through May 15, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $8,708.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver pharmaceuticals and...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $5,805.60 to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,049.51 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FUK07
    Delivery Order

The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $2,902.80 to provide the medication TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. The award does not have a set-aside designation.

Generated 4/30/24, 6:55 PM